TriplePoint Venture Growth: Another Dividend Cut Likely

TriplePoint Venture Growth is under pressure from ongoing portfolio contraction, declining income, elevated non-accruals, and severe NAV erosion, with two dividend cuts since 2024. Its non-accrual ratio is 2.5%, well above peers Hercules Capital at 0.1% and Trinity Capital at 1.1%, underscoring persistent asset quality concerns. The stock trades at 0.65x NAV versus 1.3x for HTGC and TRIN, reflecting continued loan under-performance and weak investor confidence.

Analysis

TPVG looks less like a cyclical markdown story and more like a broken funding model in a market that is already punishing venture duration risk. In a falling-rate environment, the first-order impact should have been lower funding costs and better portfolio exits, but the second-order effect is harsher: weak marks in late-stage venture credit tend to self-reinforce as borrowers lose access to follow-on capital, pushing more positions into non-accrual and compressing fair value further. That creates a negative feedback loop for NAV that can persist for multiple quarters even if headline macro improves.

The discount to NAV is justified, but the spread versus HTGC and TRIN is likely also reflecting expected dividend durability rather than just asset quality. Once a BDC cuts twice in a year, the market starts underwriting a lower run-rate payout and a lower terminal multiple, which means even “cheap” shares can stay cheap for months unless non-accruals peak and stabilize. The real winner is the higher-quality BDC complex: peers with cleaner credit books and more diversified origination should continue to attract capital at a premium, while TPVG effectively becomes a source of relative-value funding for longs in HTGC/TRIN.

Catalyst timing matters: near term, any additional portfolio markdowns or another income miss would likely trigger another leg lower because the stock is already positioned as a distressed yield vehicle. Over a 3-6 month horizon, the only credible reversal is a visible pause in non-accrual migration plus evidence that distributions are being covered without balance-sheet strain. Without that, the downside is less about a single bad quarter and more about a prolonged rerating toward a lower-quality BDC liquidation discount.

The contrarian case is that the market may be extrapolating venture stress too far into TPVG’s remaining book, creating optionality if private-markets sentiment improves and exits reopen. But this is a weak contrarian until the company proves that portfolio contraction has stopped shrinking earning assets faster than spreads can offset it. In other words, the stock is not priced for perfection; it is priced for continued impairment, and only a sustained fundamental inflection can break that.

Key Decisions for Investors

• Stay short TPVG for 1-3 months into the next earnings print; use any rally toward a tighter discount to NAV as an opportunity to add, with the thesis that another small miss or markdown can drive a disproportionate re-rating lower.
• Pair trade: long HTGC / short TPVG for 3-6 months. This isolates credit-quality dispersion in tech BDCs; upside is driven by multiple convergence toward higher-quality peers, while the main risk is a sector-wide compression if risk appetite collapses.
• If options liquidity allows, buy TPVG puts or put spreads 1-2 quarters out to express tail risk from another dividend reset. Risk/reward is attractive because the market is likely to overreact to any additional cut but underprice the probability of it.
• Do not chase the dividend yield in TPVG until non-accruals trend down for at least two consecutive quarters; the better risk-adjusted income exposure remains TRIN/HTGC, where capital return stability should support valuation.
• Set a tactical cover signal on TPVG only if NAV erosion moderates and earnings coverage improves materially; absent that, the stock remains a value trap rather than a mean-reversion candidate.